Malgorzata Pilarczyk
Overview
Explore the profile of Malgorzata Pilarczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rzymski P, Poniedzialek B, Rosinska J, Ciechanowski P, Peregrym M, Pokorska-Spiewak M, et al.
Ecotoxicol Environ Saf
. 2022 May;
239:113651.
PMID: 35594828
Air pollution, to which children are more susceptible than adults, can promote airway inflammation, potentially exaggerating the effects of respiratory viral infection. This study examined the association between the clinical...
2.
Domagalski K, Pawlowska M, Zalesna A, Pilarczyk M, Rajewski P, Halota W, et al.
World J Gastroenterol
. 2016 Nov;
22(41):9186-9195.
PMID: 27895405
Aim: To investigate the impact of IL28B and gene polymorphisms on interferon treatment responses in children with chronic hepatitis B. Methods: We enrolled 52 children (between the ages of 4...
3.
Pawlowska M, Pniewska A, Pilarczyk M, Kozielewicz D, Domagalski K
Expert Opin Drug Saf
. 2016 Jul;
15(10):1361-8.
PMID: 27402246
Introduction: An appropriate management of HBV infection is the best strategy to finally reduce the total burden of HBV infection. Mother-to-child transmission (MTCT) is responsible for more than one third...
4.
Wisniewska-Ligier M, Pawlowska M, Pilarczyk M, Halota W, Wozniakowska-Gesicka T
J Pediatr Gastroenterol Nutr
. 2013 Aug;
57(6):694-9.
PMID: 23942001
Background And Objective: The course of chronic hepatitis C in children is often mild or asymptomatic, but may lead to liver cirrhosis and neoplasm. The aim of our study was...
5.
Pawlowska M, Pilarczyk M, Foksinska A, Smukalska E, Halota W
Hepat Mon
. 2012 Feb;
11(12):968-74.
PMID: 22368680
Background: Treatment of hepatitis C virus (HCV) infection with interferon (IFN) and ribavirin (RBV) is associated with adverse events, which may affect the patient's adherence to the treatment regimen and...
6.
Pawlowska M, Pilarczyk M, Halota W
Med Sci Monit
. 2010 Dec;
16(12):CR616-21.
PMID: 21119580
Background: This study assessed the efficacy and safety of treatment of chronic hepatitis C in children with pegylated interferon alpha and ribavirin. Material/methods: Investigations were performed on 53 children with...
7.
Smukalska E, Pawlowska M, Kozielewicz D, Dura B, Pilarczyk M, Zarzycka-Chrol E
Przegl Epidemiol
. 2008 Jun;
62(1):107-12.
PMID: 18536232
The results of retrospective analysis of 97 children treated at Observation and Liver Diseases Unit in Bydgoszcz between 1st Jun and 30th Jun 2006 because of retrovirus diarrhea were presented....
8.
Pilarczyk M, Pawlowska M, Jendryczka E
Przegl Epidemiol
. 2008 Jun;
62(1):101-5.
PMID: 18536231
Unlabelled: The aim of the study was an assessment of retherapy in children with chronic hepatitis C. Investigations were performed in 41 children divided on 2 groups (A and B)....
9.
Dybowska D, Pilarczyk M
Przegl Epidemiol
. 2005 Apr;
58 Suppl 1:139-43.
PMID: 15807174
The aim of the study was comparison of the efficacy of treatment with INF and lamivudine in chronic hepatitis B. 103 patients with chronic hepatitis B were included in this...